Truist keeps Hold on OrthoPediatrics and Landstar, sets $28 and $160 targets

what happened

TradingView reports that Truist Securities kept its Hold rating on OrthoPediatrics stock with a $28.00 price target. The target implies a 17.5% gain from the October 27 close of $23.82. Analysts point to 19% year-over-year revenue growth, led by Cannulated Screws and PediPlates, but expect the company to struggle to accelerate further, and see its valuation as too high to justify a buy rating for now.

Truist also kept its Hold rating on Landstar System with a $160.00 target. That implies a 5.2% decline from the October 27 close of $168.78. Analysts highlight the asset-light model and stable margins, but flag uncertainty around insurance and claims costs and litigation risk. As a result, better freight volumes and pricing may not translate into a significant earnings increase.

Other recent notes on KIDS from Cowen, Stifel, Piper Sandler and BTIG carry price targets between $27 and $30.

why it matters

A Hold rating from a single brokerage rarely moves the market on its own, but it shows analysts seeing limited upside in both stocks. Such notes are best read alongside other broker views and the companies' own results.

tags

instruments